Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

NCT02204163 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Prader-Willi Syndrome

Interventions

DRUG: Eutropin
DRUG: Genotropin

Sponsor

LG Life Sciences